During the past decade, Integris Cardiovascular Physicians conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Integris Cardiovascular Physicians" #1 sponsor was "Abiomed Inc." with 1 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Terumo Medical Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Integris Cardiovascular Physicians" #1 collaborator was "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator, "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator and "Yale University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Integris Cardiovascular Physicians" are "Arthritis, Rheumatoid" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials) and "High Cardiovascular Risk" (1 trials). Many other conditions were trialed in "Integris Cardiovascular Physicians" in a lesser frequency.

Most popular intervention types in "Integris Cardiovascular Physicians" are "Drug" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "ABIOMED, Inc. hemodynamic support devices" (1 trials), "Acetylsalicylic acid" (1 trials), "Apixaban" (1 trials), "Cross-Seal System" (1 trials) and "Ibuprofen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Integris Cardiovascular Physicians" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Integris Cardiovascular Physicians". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Integris Cardiovascular Physicians, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Integris Cardiovascular Physicians, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".